Alvotech announced Q1 2026 revenues of $105.9 million, down from $132.8 million last year, impacted by production slowdowns due to facility improvements. Adjusted EBITDA was $24.4 million with a gross margin of 57%. The company progressed its biosimilar pipeline, submitting marketing applications for two products to the European Medicines Agency and starting a pivotal study for a US submission in 2028. A new manufacturing agreement with FUJIFILM Biotechnologies was established to diversify supply. Management expects 2026 revenues between $650-$700 million and adjusted EBITDA of $180-$220 million, anticipating recovery as operations normalize and new launches occur.
Sodexo has secured a major global contract to provide catering services across more than 130 Meta sites in over 30 countries. This large-scale partnership includes diverse locations such as headquarters, campuses, data centers, and conference centers...
DMG Blockchain Solutions announced two strategic investments: one in MeetAmi Innovations, a Canadian fintech offering digital asset wealth management platforms, and another in Atomic47 Labs, an AI company focused on secure, sovereign AI infrastructur...
Gnosis (GNO) surged 13% in 24 hours, closing in on overtaking BONK by market capitalization to reach the 100th largest token spot. GNO's market cap stands at $303.88 million versus BONK's $330.07 million, requiring a price rise to about $125.48 for t...
Broadridge's Tokenization Pulse Survey shows 84% of firms view tokenization as strategically important, with 68% expecting it to reshape markets within 3-5 years. Most firms plan to integrate tokenization into existing infrastructure rather than buil...
Standard Chartered has partnered with Broadcom to modernize its global banking infrastructure by adopting a secure, resilient private cloud using VMware Cloud Foundation. This upgrade supports critical banking services across 54 markets with enhanced...
